Compare with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. DATSONS LABS ALKEM LABORATORIES/
DR. DATSONS LABS
 
P/E (TTM) x 21.9 -10.9 - View Chart
P/BV x 5.3 0.2 3,249.4% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 ALKEM LABORATORIES   DR. DATSONS LABS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
DR. DATSONS LABS
Mar-14
ALKEM LABORATORIES/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs2,720126 2,165.6%   
Low Rs1,66031 5,373.3%   
Sales per share (Unadj.) Rs697.9133.0 524.7%  
Earnings per share (Unadj.) Rs96.10.2 63,399.3%  
Cash flow per share (Unadj.) Rs117.36.6 1,774.6%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs515.2128.8 400.1%  
Shares outstanding (eoy) m119.5731.66 377.7%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x3.10.6 533.4%   
Avg P/E ratio x22.8516.1 4.4%  
P/CF ratio (eoy) x18.711.8 157.7%  
Price / Book Value ratio x4.30.6 699.6%  
Dividend payout %26.00-   
Avg Mkt Cap Rs m261,8792,477 10,570.7%   
No. of employees `00014.3NA-   
Total wages/salary Rs m15,05556 26,883.8%   
Avg. sales/employee Rs Th5,822.6NM-  
Avg. wages/employee Rs Th1,050.5NM-  
Avg. net profit/employee Rs Th802.0NM-  
INCOME DATA
Net Sales Rs m83,4444,211 1,981.8%  
Other income Rs m1,04279 1,324.3%   
Total revenues Rs m84,4864,289 1,969.7%   
Gross profit Rs m14,734569 2,591.3%  
Depreciation Rs m2,528204 1,236.6%   
Interest Rs m651430 151.2%   
Profit before tax Rs m12,59813 99,196.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1056 18,111.5%   
Profit after tax Rs m11,4935 239,439.6%  
Gross profit margin %17.713.5 130.8%  
Effective tax rate %8.848.0 18.3%   
Net profit margin %13.80.1 12,081.9%  
BALANCE SHEET DATA
Current assets Rs m54,9606,852 802.2%   
Current liabilities Rs m32,4336,711 483.3%   
Net working cap to sales %27.03.3 806.2%  
Current ratio x1.71.0 166.0%  
Inventory Days Days80161 49.5%  
Debtors Days Days72318 22.7%  
Net fixed assets Rs m32,7103,673 890.5%   
Share capital Rs m239317 75.5%   
"Free" reserves Rs m61,3683,761 1,631.7%   
Net worth Rs m61,6074,078 1,510.9%   
Long term debt Rs m1,5921,671 95.3%   
Total assets Rs m99,43312,633 787.1%  
Interest coverage x20.41.0 1,978.0%   
Debt to equity ratio x00.4 6.3%  
Sales to assets ratio x0.80.3 251.8%   
Return on assets %12.23.4 354.7%  
Return on equity %18.70.1 15,847.5%  
Return on capital %21.07.7 273.2%  
Exports to sales %19.122.9 83.3%   
Imports to sales %3.014.3 20.8%   
Exports (fob) Rs m15,917964 1,651.2%   
Imports (cif) Rs m2,483602 412.5%   
Fx inflow Rs m16,061964 1,666.1%   
Fx outflow Rs m2,483607 409.0%   
Net fx Rs m13,578357 3,804.5%   
CASH FLOW
From Operations Rs m5,8511,345 435.1%  
From Investments Rs m-7,414-2,256 328.7%  
From Financial Activity Rs m792-1,200 -66.0%  
Net Cashflow Rs m-731-2,111 34.6%  

Share Holding

Indian Promoters % 66.9 4.5 1,476.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.0 -  
FIIs % 0.0 1.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 94.1 -  
Shareholders   68,381 20,807 328.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ELDER PHARMA  FDC  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Feb 26, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - GSK PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS